Compare COUR & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COUR | NEO |
|---|---|---|
| Founded | 2012 | 2001 |
| Country | United States | United States |
| Employees | N/A | 2500 |
| Industry | Computer Software: Prepackaged Software | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 932.9M | 1.2B |
| IPO Year | 2021 | 2008 |
| Metric | COUR | NEO |
|---|---|---|
| Price | $5.28 | $9.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 8 |
| Target Price | $10.53 | ★ $13.38 |
| AVG Volume (30 Days) | ★ 6.6M | 2.0M |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.22 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $757,500,000.00 | N/A |
| Revenue This Year | $9.43 | $10.63 |
| Revenue Next Year | $6.40 | $9.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.04 | N/A |
| 52 Week Low | $5.00 | $4.72 |
| 52 Week High | $13.56 | $13.74 |
| Indicator | COUR | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 44.26 | 60.46 |
| Support Level | $5.09 | $7.42 |
| Resistance Level | $6.41 | $10.82 |
| Average True Range (ATR) | 0.31 | 0.40 |
| MACD | -0.05 | 0.04 |
| Stochastic Oscillator | 22.62 | 89.45 |
Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.